Skip to content

The greater omental flap to cover the cut surface of the liver for prevention of delayed gastric emptying after left-sided hepatobiliary resection

The greater omental flap to cover the cut surface of the liver for prevention of delayed gastric emptying after left-sided hepatobiliary resection: a prospective randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN65426707
Enrollment
40
Registered
2010-01-19
Start date
2007-06-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed gastric emptying Surgery Malignant neoplasm of liver and intrahepatic bile ducts

Interventions

Patients were randomised to undergo left-sided hepatobiliary resection 1. With greater omental flap to cover the cut surface of the liver 2. Without greater omental flap

Sponsors

Nagoya University Graduate School of Medicine (Japan) - Division of Surgical Oncology, Department of Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients scheduled to undergo left-sided hepatobiliary resection for cholangiocarcinoma at the Nagoya University Hospital

Exclusion criteria

Exclusion criteria: 1. Patients scheduled to undergo other gastrointestinal resection, including hepatopancreaticoduodenectomy 2. Previous gastrointestinal resection 3. Aged over 20 years, either sex

Design outcomes

Primary

MeasureTime frame
Clinical grading of DGE based on the International Study Group of Pancreatic Surgery (ISGPS) classification. DGE was classified with regard to the duration of naso-gastric tube (NGT) requirement and/or need for re-insertion of NGT, and the postoperative day (POD) when solid food intake was tolerated after surgery. To assess DGE, once solid food intake was stablised, a radiopaque marker was administered. Abdominal X-rays were taken 1, 2, 3, 4, 5, and 6 hours after the administration of the marker.

Secondary

MeasureTime frame
No secondary outcome measures

Countries

Japan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026